Neuren Pharmaceuticals | 보통주 자본



Ordinary Share Capital 변화 날짜
Alaunos Therapeutics USD 2K 0 2024-12
Clinuvel Pharmaceuticals AUD 168.8M 754.23K 2024-06
Dianthus Therapeutics USD 32.18M 32.15M 2025-06
Genetic Signatures AUD 127.64M 8.22M 2024-12
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Medical Developments International AUD 115.01M 9.28M 2024-12
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Organon & Co USD 259.96M 256.96M 2025-06
Paradigm Biopharmaceuticals AUD 253.24M 15.12M 2024-12
PYC Therapeutics AUD 230.58M 0 2024-12
Starpharma Holdings AUD 240.75M 0 2024-12
Tectonic Therapeutic USD 18.71M 18.71M 2025-06
Telix Pharmaceuticals AUD 334.72M 252.68M 2024-12
Viatris USD 1.17B 1.15B 2025-06
Xeris Pharmaceuticals USD 161.22M 161.21M 2025-06


Neuren Pharmaceuticals 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Sep 2025.